Dolby Laboratories (NYSE:DLB – Get Free Report) CAO Ryan Nicholson sold 1,348 shares of the firm’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $62.04, for a total transaction of $83,629.92. Following the transaction, the chief accounting officer directly owned 35,636 shares in the company, valued at $2,210,857.44. The trade was a 3.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Ryan Nicholson also recently made the following trade(s):
- On Tuesday, August 4th, Ryan Nicholson sold 357 shares of Dolby Laboratories stock. The stock was sold at an average price of $60.63, for a total transaction of $21,644.91.
Dolby Laboratories Stock Performance
Shares of DLB stock opened at $62.41 on Friday. The company has a market capitalization of $5.85 billion, a price-to-earnings ratio of 26.56 and a beta of 0.80. Dolby Laboratories has a 52-week low of $48.26 and a 52-week high of $75.66. The company has a 50-day simple moving average of $53.52 and a two-hundred day simple moving average of $58.48.
Dolby Laboratories Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th will be given a dividend of $0.36 per share. The ex-dividend date of this dividend is Tuesday, August 11th. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 61.28%.
Dolby Laboratories announced that its board has approved a share buyback program on Thursday, July 30th that allows the company to buyback $350.00 million in outstanding shares. This buyback authorization allows the electronics maker to purchase up to 7% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on DLB. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings lowered shares of Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a research note on Friday, July 31st. Finally, Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $83.00.
Read Our Latest Stock Analysis on DLB
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the company. Royal Bank of Canada increased its holdings in Dolby Laboratories by 3.5% in the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock worth $5,491,000 after acquiring an additional 2,298 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in Dolby Laboratories by 218.8% during the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after purchasing an additional 171,288 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Dolby Laboratories by 5.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock valued at $19,131,000 after purchasing an additional 12,598 shares during the last quarter. Focus Partners Wealth bought a new position in Dolby Laboratories during the first quarter worth about $390,000. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Dolby Laboratories by 273.3% in the second quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock worth $193,000 after purchasing an additional 1,902 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Recommended Stories
- Five stocks we like better than Dolby Laboratories
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
